HomeCNSP • NASDAQ
add
CNS Pharmaceuticals Inc
Previous close
$0.13
Day range
$0.11 - $0.13
Year range
$0.10 - $135.00
Market cap
6.17M USD
Avg Volume
29.85M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.63M | 24.15% |
Net income | -5.61M | -23.95% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.63M | -24.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.97M | 666.66% |
Total assets | 7.41M | 218.26% |
Total liabilities | 4.06M | -0.29% |
Total equity | 3.35M | — |
Shares outstanding | 57.49M | — |
Price to book | 1.30 | — |
Return on assets | -284.91% | — |
Return on capital | 3,576.99% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.61M | -23.95% |
Cash from operations | -6.80M | -101.40% |
Cash from investing | — | — |
Cash from financing | 12.28M | 146,826.13% |
Net change in cash | 5.48M | 262.67% |
Free cash flow | -5.89M | -194.68% |
About
Founded
2017
Headquarters
Website
Employees
3
